Basics |
India Globalization Capital, Inc.
India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
|
IPO Date: |
June 1, 2006 |
Sector: |
Industrials |
Industry: |
Trading Companies and Distributors |
Market Cap: |
$28.49M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.08 | 5.49%
|
Avg Daily Range (30 D): |
$0.01 | 3.61%
|
Avg Daily Range (90 D): |
$0.01 | 3.80%
|
Institutional Daily Volume |
Avg Daily Volume: |
.79M |
Avg Daily Volume (30 D): |
3.79M |
Avg Daily Volume (90 D): |
1.42M |
Trade Size |
Avg Trade Size (Sh.): |
343 |
Avg Trade Size (Sh.) (30 D): |
477 |
Avg Trade Size (Sh.) (90 D): |
482 |
Institutional Trades |
Total Inst.Trades: |
85 |
Avg Inst. Trade: |
$2.55M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
.23M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.15M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
473.34K |
|
|
Financials |
|
TTM |
Q4 2025 |
FY 2025 |
Basic EPS
|
$-.09
|
|
$-.09
|
Diluted EPS
|
$-.09
|
|
$-.09
|
Revenue
|
$ 1.27M
|
$
|
$ 1.27M
|
Gross Profit
|
$ .62M
|
$
|
$ .62M
|
Net Income / Loss
|
$ -7.12M
|
$
|
$ -7.12M
|
Operating Income / Loss
|
$ -7.45M
|
$
|
$ -7.45M
|
Cost of Revenue
|
$ .65M
|
$
|
$ .65M
|
Net Cash Flow
|
$ -.79M
|
$
|
$ -.79M
|
PE Ratio
|
|
|
|
Splits |
Apr 19, 2013:
1:10
|
|
|
|